ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ESMO 2022 on the Phase 3 CodeBreaK 200 Trial: Sotorasib Demonstrates Superior PFS vs. Docetaxel for Previously Treated NSCLC With KRAS G12C Mutation
By
ecancer
FEATURING
Melissa Johnson
By
ecancer
FEATURING
Melissa Johnson
Login to view comments.
Click here to Login
